Market News & Trends
Ligand Partner GSK Announces Results of Phase III PETIT2 Study
Ligand Pharmaceuticals Incorporated recently announced that its partner, GlaxoSmithKline (GSK) plc, presented the results from the Phase III PETIT2 study evaluating the efficacy of eltrombopag…
Lucrative Biosimilars Space to Erode Biologics Market From 2019
The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate…
Xcelience Opens UK/European Packaging & Distribution Hub
Xcelience recently announced the opening of a 3,000-sq-ft facility in Birmingham, UK, making it the first small- to mid-sized American CDMO to launch international operations.…
Celgene Exercises Option for Agios Pharmaceuticals’ Lead Cancer Drug
Agios Pharmaceuticals, Inc. recently announced its partner Celgene Corporation has exercised its option to an exclusive worldwide license to AG-221, an oral, first-in-class, potent inhibitor…
Isis Pharmaceuticals Earns $15 Million From AstraZeneca
Isis Pharmaceuticals, Inc.recently announced that AstraZeneca has initiated a Phase I clinical study of ISIS-ARRx in patients with cancer. Isis earned a $15-million milestone payment…
Lucrative Biosimilars Space to Erode Biologics Market From 2019
The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate…
Agalimmune Receives $2-Million) Milestone Payment
Agalimmune Ltd recently announced it has received a milestone payment from Loxbridge Research LLP and Animatrix Finance Ltd following successful completion of two Phase I…
Key Patent Expiries to Lead Global Anti-Hypertensive Market
Multiple major drug patent expiries will cause the global anti-hypertensive market value to decline from $40 billion in 2013 to $37.6 billion by 2020, at…
NanoString Technologies & Celgene Enter $45-Million Collaboration
NanoString Technologies, Inc. recently announced it has entered into a collaboration with Celgene Corporation to develop a companion diagnostic assay using the nCounter Analysis System…
Profiling Metal Content in Parenteral Grade Protein Stabilizers
By: Jason Forbes, Larry Lonski, and Christopher Wilcox Sucrose, Trehalose, Mannitol, and Maltose are four of the most commonly utilized carbohydrates for protein stabilization in…
Halozyme to Resume Pancreatic Cancer Trial
Halozyme Therapeutics, Inc. recently announced that the US FDA has removed the clinical hold on patient enrollment and dosing of PEGPH20 in the ongoing Phase…
Transition Therapeutics to Receive up to $30.8 Million
Transition Therapeutics Inc. recently announced that Jack W. Schuler , Larry N. Feinberg, Oracle Investment Management, certain Transition Board members, management, and other existing shareholders…
Lubrizol Introduces New Pharmaceutical Excipient
The Lubrizol LifeScience Polymers (LSP) business announces the introduction of a new pharmaceutical-grade excipient, Pathway. As pharmaceutical companies face the challenge of the patent cliff,…
Ipca & Oncobiologics Create Strategic Biosimilars Partnership
Ipca Laboratories Ltd. and Oncobiologics, Inc. recently announced the creation of a two-part alliance for the development, manufacture, and commercialization of biosimilar monoclonal antibody products.…
Personalized Medicine Drives Uptake of Next-Generation Sequencing in Europe, Finds Frost & Sullivan
The Western European next-generation sequencing (NGS) market is poised for steady growth, owing to the emergence of new applications, such as non-invasive prenatal testing and…
Vietnam’s Pharmaceutical Market Value to Hit $8 Billion by 2020
The pharmaceutical market in Vietnam is set to increase in value by $5 billion over the next 6 years, reaching a net worth of $8…
A Rise in IPOs Revive Investments for Global Pharma & Biotech Industry
The heightened private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008-2010, witnessed a decline post-2010. However,…
Novozymes Biopharma Enters Agreement With Leading Vaccine Company
Novozymes Biopharma has entered a new collaborative research agreement with one of the world’s top vaccine companies. The partnership will enable the company to evaluate…
Capsugel & Bend Research Announce New Commercial-Scale Spray-Dried Dispersion Capacity
Bend Research, a division of Capsugel Dosage Form Solutions (DFS), recently announced it has installed its first commercial-scale spray-dryer in its R&D facility in Bend,…
A Rise in IPOs Revive Investments for Global Pharma & Biotech Industry
The heightened private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008-2010, witnessed a decline post-2010.…
